-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to statistics, lung cancer is one of the most common malignant tumors worldwide, accounting for the highest proportion of cancer deaths
Even with radical resection, 20% to 52% of stage I-III patients develop local recurrence or distant metastasis
Current guidelines recommend the use of [ 18 18 F]FDG PET/CT for initial staging of all NSCLC patients
Classical PET variables, such as standardized uptake value (SUV)-based and volume-based variables, such as metabolic tumor volume (MTV) and lesion total glycolysis (TLG), have been identified as important prognostic factors in multiple studies , but The results are not consistent .
Recently, a study published in the journal European Radiology explored two new geometric variables, the normalized SUVpeak -to-centre distance ( nSCD ) and normalized The prognostic value of SUVmax-to-periphery distance (nSPD) and its correlation with classical metabolic parameters in NSCLC patients undergoing surgery .
This retrospective study enrolled patients with stage I-III NSCLC with baseline [ 18 18 F]FDG PET/CT and obtained clinical, histopathological, and metabolic parameters for each patient .
A total of 173 patients were included in this study .
The results of this study demonstrate that nSCD and nSPD can be used as predictors of poor prognosis in NSCLC patients, outperforming classical PET-derived variables
Original source:
Germán Andrés Jiménez Londoño, Ana Maria García Vicente, Jesús J Bosque, et al.
Germán Andrés Jiménez Londoño, Ana Maria García Vicente, Jesús J Bosque, et al.
SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients.
DOI: 10.
1007/s00330-021-08523-3 SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients.
10.
1007/s00330-021-08523-3
Leave a comment here